NCT05917041View on ClinicalTrials.gov

Exploratory Study of SAT-001 in Treatment of Pediatric Patient With Myopia

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

April 19, 2023

Study Completion Date

April 3, 2024

Conditions
Children Myopia
Interventions
DEVICE

SAT-001(Software as Medical Device)

Using SAT-001 application for 48 weeks and wearing glasses or not

Trial Locations (6)

Unknown

HanGil Eye Hospital, Incheon

Kangbuk Samsung Medical Center, Seoul

Konkuk University Medical Center, Seoul

Nowon Eulji Medical Center, Eulji University, Seoul

Samsung Medical Center, Seoul

Seoul Asan Medical Center, Seoul

All Listed Sponsors
lead

S-Alpha Therapeutics, Inc.

INDUSTRY

NCT05917041 - Exploratory Study of SAT-001 in Treatment of Pediatric Patient With Myopia | Biotech Hunter | Biotech Hunter